Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Fath

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Deutsches Arzteblatt International|June 16, 2026
Lacking EvidenceFelix Fath, Marcus E Kleber, Gerald Klose
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 17, 2025
Statins for primary prevention of cardiovascular disease in Germany: benefits and costsAlexander Dressel, Felix Fath, Bernhard K Krämer, et al.
Vascular Pharmacology|June 18, 2019
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohortAlexander Dressel, Burkhard Schmidt, Nina Schmidt, et al.
Scientific Reports|October 15, 2021
FH ALERT: efficacy of a novel approach to identify patients with familial hypercholesterolemiaFelix Fath, Andreas Bengeser, Mathias Barresi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Deutsches Arzteblatt International|June 16, 2026
Lacking EvidenceFelix Fath, Marcus E Kleber, Gerald Klose
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 17, 2025
Statins for primary prevention of cardiovascular disease in Germany: benefits and costsAlexander Dressel, Felix Fath, Bernhard K Krämer, et al.
Vascular Pharmacology|June 18, 2019
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohortAlexander Dressel, Burkhard Schmidt, Nina Schmidt, et al.
Scientific Reports|October 15, 2021
FH ALERT: efficacy of a novel approach to identify patients with familial hypercholesterolemiaFelix Fath, Andreas Bengeser, Mathias Barresi, et al.
Pageof 1